428 filings
10-Q
2024 Q1
HEPA
Hepion Pharmaceuticals Inc
Quarterly report
21 May 24
5:08pm
NT 10-Q
HEPA
Hepion Pharmaceuticals Inc
15 May 24
Notice of late quarterly filing
4:46pm
10-K
2023 FY
HEPA
Hepion Pharmaceuticals Inc
Annual report
16 Apr 24
4:53pm
NT 10-K
HEPA
Hepion Pharmaceuticals Inc
1 Apr 24
Notice of late annual filing
4:30pm
8-K
HEPA
Hepion Pharmaceuticals Inc
6 Mar 24
Departure of Directors or Certain Officers
4:15pm
8-K
86bvo
20 Feb 24
Departure of Directors or Certain Officers
4:15pm
8-K
813a7twt47fpfkot0
16 Feb 24
Entry into a Material Definitive Agreement
9:02am
8-K
vju 0tzwh113
7 Feb 24
Departure of Directors or Certain Officers
4:15pm
8-K
sw59esfv6k zxs59m
3 Jan 24
Changes in Registrant's Certifying Accountant
4:30pm
8-K
ah7m5h4
7 Dec 23
Hepion Pharmaceuticals Announces Restructuring Plan to Enhance Shareholder Value and Management Changes
8:41am
NT 10-Q
3hxn92ko3tp6v 2d8p22
14 Nov 23
Notice of late quarterly filing
4:46pm
EFFECT
uxypl 8dnylt82w2xecf
9 Nov 23
Notice of effectiveness
12:15am
CORRESP
h3yhweesvo5
6 Nov 23
Correspondence with SEC
12:00am
UPLOAD
irx2majfe
3 Nov 23
Letter from SEC
12:00am
D
eur017 det9q
3 Oct 23
$5.00 mm in equity / options, sold $5.00 mm, 1 investor
5:22pm
8-K
h78a2 g9tck0t
2 Oct 23
Hepion Pharmaceuticals Announces $5.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under Nasdaq Rules
6:29pm
424B5
fuvii
2 Oct 23
Prospectus supplement for primary offering
4:52pm
8-K
s8azav
6 Sep 23
Departure of Directors or Certain Officers
4:40pm